Moneycontrol PRO
HomeNewsMaxhealthcareinstitute
Jump to
  • Buy Max Healthcare Institute; target of Rs 1355: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 1355 in its research report dated August 14, 2025.

  • Max Healthcare Q1 FY26: Scaling up amid rich valuations

    Max Healthcare Q1 FY26: Scaling up amid rich valuations

    Max plans to increase its capacity by ~70 percent to reach ~9,000 beds by FY28.

  • Buy Max Healthcare Institute; target of Rs 1300: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 1300: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated May 22, 2025.

  • Buy Max Healthcare Institute; target of Rs 1300: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 1300: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated February 01, 2025.

  • Buy Max Healthcare Institute target of Rs 1200 Prabhudas Lilladher

    Buy Max Healthcare Institute target of Rs 1200 Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated November 08, 2024.

  • Buy Max Healthcare; target of Rs 1240: Motilal Oswal

    Buy Max Healthcare; target of Rs 1240: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare has recommended buy rating on the stock with a target price of Rs 1240 in its research report dated November 07, 2024.

  • Buy Max Healthcare; target of Rs 1240: Motilal Oswal

    Buy Max Healthcare; target of Rs 1240: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 1240 in its research report dated September 20, 2024.

  • Buy Max Healthcare Institute; target of Rs 975: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 975: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 975 in its research report dated August 02, 2024.

  • Buy Max Healthcare; target of Rs 930: Motilal Oswal

    Buy Max Healthcare; target of Rs 930: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare has recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 23, 2024.

  • What should you do with Max Healthcare’s stock?

    What should you do with Max Healthcare’s stock?

    Near-term outlook should support the stock momentum; however, valuations stand elevated

  • Buy Max Healthcare; target of Rs 700: Motilal Oswal

    Buy Max Healthcare; target of Rs 700: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 700 in its research report dated November 07, 2023.

  • Buy Max Healthcare Institute; target of Rs 675: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 675: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 675 in its research report dated November 07, 2023.

  • Buy Max Healthcare; target of Rs 660: Motilal Oswal

    Buy Max Healthcare; target of Rs 660: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 660 in its research report dated August 30, 2023.

  • Buy Max Healthcare Institute; target of Rs 610: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 610: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 610 in its research report dated August 09, 2023.

  • Buy Max Healthcare; target of Rs 650: Motilal Oswal

    Buy Max Healthcare; target of Rs 650: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 650 in its research report dated August 08, 2023.

  • Buy Max Healthcare Institute; target of Rs 565: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 565: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 565 in its research report dated May 17, 2023.

  • Buy Max Healthcare; target of Rs 600: Motilal Oswal

    Buy Max Healthcare; target of Rs 600: Motilal Oswal

    Motilal Oswal is bullish on Max Healthcare recommended buy rating on the stock with a target price of Rs 600 in its research report dated May 17, 2023.

  • Buy MAX Healthcare; target of Rs 530: Motilal Oswal

    Buy MAX Healthcare; target of Rs 530: Motilal Oswal

    Motilal Oswal is bullish on MAX Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated April 06, 2023.

  • Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 500 in its research report dated February 05, 2023.

  • Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 500 in its research report dated November 03, 2022.

  • Buy Max Healthcare Institute; target of Rs 427: Prabhudas Lilladher

    Buy Max Healthcare Institute; target of Rs 427: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Max Healthcare Institute has recommended buy rating on the stock with a target price of Rs 427 in its research report dated August 13, 2022.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347